APA (7th ed.) Citation

DN, B., YK, C., RH, W., J, B., HJ, K., GT, N., . . . AA, V. (1998). Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. Journal of immunology (Baltimore, Md. : 1950), 161(2), 1034.

Chicago Style (17th ed.) Citation

DN, Bourdette, et al. "Immunity to T Cell Receptor Peptides in Multiple Sclerosis. III. Preferential Immunogenicity of Complementarity-determining Region 2 Peptides from Disease-associated T Cell Receptor BV Genes." Journal of Immunology (Baltimore, Md. : 1950) 161, no. 2 (1998): 1034.

MLA (9th ed.) Citation

DN, Bourdette, et al. "Immunity to T Cell Receptor Peptides in Multiple Sclerosis. III. Preferential Immunogenicity of Complementarity-determining Region 2 Peptides from Disease-associated T Cell Receptor BV Genes." Journal of Immunology (Baltimore, Md. : 1950), vol. 161, no. 2, 1998, p. 1034.